Division of Cardiovascular Medicine, Department of Internal Medicine, Jichi Medical University.
Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University.
Int Heart J. 2023;64(2):316-320. doi: 10.1536/ihj.22-563.
Pulmonary arterial hypertension (PAH) is a rare and fatal disease for which some causative drugs have been developed. Qing-Dai is a Chinese herbal drug that is sometimes used as a specific treatment for ulcerative colitis in Asia, including Japan. Here, we report a case of severe Qing-Dai-induced PAH. A 19-year-old woman who has been taking Qing-Dai for 8 months was admitted for exertional dyspnea. Her mean pulmonary artery pressure dramatically improved from 72 to 18 mmHg with Qing-Dai discontinuation and PAH-specific therapy. After 6 years of onset, she had not relapsed with PAH with PAH-specific therapy.
肺动脉高压(PAH)是一种罕见且致命的疾病,已经开发出一些针对其病因的药物。青黛是一种中草药,在亚洲,包括日本,有时被用作溃疡性结肠炎的特定治疗药物。在这里,我们报告了一例严重的青黛引起的 PAH。一名 19 岁女性因运动性呼吸困难而入院,她已服用青黛 8 个月。停止服用青黛并采用肺动脉高压特异性治疗后,其平均肺动脉压从 72mmHg 显著改善至 18mmHg。发病 6 年后,她仍未复发肺动脉高压,且持续接受肺动脉高压特异性治疗。